AzTrials
AzTrials

Low VisionPhase 1NCT04190134

Socially Assistive Robots to Enhance Magnification Device Use for Reading

A Phase 1 study testing Socially Assistive Robot for Low Vision Rehabilitation in people with Low Vision, run by University of California, Los Angeles at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aims of this exploratory research project are to customize, deploy and evaluate the preliminary efficacy of a socially assistive robot as a novel approach to motivate and encourage optimal, long-term use of new magnification devices for reading in individuals with vision loss. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Low Vision
What is being tested?
Socially Assistive Robot for Low Vision Rehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited States
Study dates
22 Apr 2022to Feb 2025
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Individuals with any level of vision loss due to any ocular disease,
  • age 18 and older,
  • received a magnification device(s) (i.e., hand-held optical magnifiers, portable electronic video magnifiers, some stand magnifiers and CCTVs) from the UCLA Vision Rehabilitation Center.

Who cannot join

  • schedules not permitting participation in planned study sessions or visits (including planning to move or take extended vacation during study period),
  • inability to understand study procedures or communicate responses to visual stimuli in a consistent manner (cognitive impairment as per TICS),
  • substance abuse,
  • significant hearing loss (unable to hear communication by phone or from robot),
  • significant medical condition likely to limit participation or lifespan,
  • their magnifier device has features that would not work in conjunction with the beacon sensors: (1) hands-free and do not have a place where the patient's hand is holding the device during use (therefore, they would not register a significant change in temperature), and/or (2) no surface area of at least 1"x1" to which the beacon sensor could be attached without interfering with the device.

Trial locations and contacts

1 site in 1 country.

Ava K Bittner, OD, PhD contact

310-206-4649

abittner@mednet.ucla.edu

United States1 site, 1 recruiting
  • UCLA Stein Eye Institute

    Los Angeles, California, 90095

    Ava K Bittner, OD, PhD, 310-206-4649

    Ava K Bittner, OD, PhD

    Recruiting

Other trials in United States

About this study

Official title: Development of a Behavioral Intervention With Socially Assistive Robots to Enhance Magnification Device Use for Reading

The aims of this exploratory research project are to customize, deploy and evaluate the preliminary efficacy of a socially assistive robot as a novel approach to motivate and encourage optimal, long-term use of new magnification devices for reading in individuals with vision loss. The goals are to promote patient acceptance, adherence and skills reinforcement to achieve proficiency in the use of the magnifier, in order to attempt to reduce visual disability while performing important daily activities, such as reading tasks. This is a high priority given the increasing prevalence of low vision, paucity of low vision rehabilitation providers, and barriers related to access to care, such as transportation and geography, all of which motivate the development of this complementary approach for the provision of additional support at home by the socially assistive robot.

Conditions
Low Vision
Being tested
Socially Assistive Robot for Low Vision Rehabilitation
Keywords
robot
Medical subject headings
Vision, Low

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Socially Assistive Robot for Low Vision RehabilitationBehavioural

    A socially assistive robot will be customized to engage in dialog and conversations to motivate and encourage optimal use of new magnification devices for reading at home by individuals with vision loss.

Study groups in NCT04190134
Study groupRoleWhat they receive
Immediate RobotExperimentalOne month after study entry, participants will receive the robot at home for two months, followed by a three month observation period without the robot.
Receives: Behavioral: Socially Assistive Robot for Low Vision Rehabilitation
Delayed/Waitlist RobotActive comparatorThree months after study entry, participants will receive the robot at home for three months.
Receives: Behavioral: Socially Assistive Robot for Low Vision Rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Activity Inventory

    questionnaire; scores will be Rasch analyzed in logic units with higher or positive scores indicating less difficulty (i.e., improvement)

    Measured: change from 1 month post-enrollment to 2-3 months after receiving the socially assistive robot

Secondary outcomes (8)
  1. MNread

    reading test

    Measured: For Immediate robot: baseline, 1 month, 3 months, 6 months. For Delayed/Waitlist robot: baseline, 3 months, 6 months.

  2. Sustained Silent Reading Test

    reading test

    Measured: baseline and monthly for 6 months

  3. Geriatric Depression Scale (GDS)

    questionnaire; scale ranges from 0 to 15 with higher values indicating greater depression

    Measured: baseline and monthly for 6 months

  4. PANAS

    questionnaire; scale ranges from 10 to 50 with higher values indicating greater positive moods

    Measured: baseline and monthly for 6 months

  5. Perceived Stress Scale

    questionnaire; scale ranges from 0 to 56 with higher values indicating greater perceived stress

    Measured: baseline and monthly for 6 months

  6. 3-item UCLA Loneliness Scale

    questionnaire; scale ranges from 3 to 9 with higher values indicating greater loneliness

    Measured: baseline and monthly for 6 months

  7. Duke Social Support Index

    questionnaire; scale ranges from 10 to 30 with higher values indicating greater social support

    Measured: baseline and monthly for 6 months

  8. Almere

    questionnaire; scale ranges from 41 to 205 with higher values indicating greater acceptance of robots

    Measured: 1 month post-enrollment and 2-3 months after receiving the socially assistive robot

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Dec 2019
  2. Study start22 Apr 2022
  3. Primary completionFeb 2025 (estimated)
  4. Study completionFeb 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04190134
Sponsor's protocol ID
19-001429
Status last verified
Jul 2024
First submitted
3 Dec 2019
Last updated
19 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Socially Assistive Robot for Low Vision Rehabilitation in people with Low Vision, run by University of California, Los Angeles at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ava K Bittner, OD, PhD (310-206-4649, abittner@mednet.ucla.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Activity Inventory (time frame: change from 1 month post-enrollment to 2-3 months after receiving the socially assistive robot). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in